ライフサイエンスコーパス: ventricular fibrillation

1 arrest or sustained ventricular tachycardia/ventricular fibrillation).

2 ricular arrhythmias (ventricular tachycardia/ventricular fibrillation).

3 , hyperkalemia, or primary arrhythmia (i.e., ventricular fibrillation).

4 ion MI, and 8.9% had ventricular tachycardia/ventricular fibrillation.

5 ignificant increase in response times to the ventricular fibrillation.

6 nin-angiotensin system (RAS), culminating in ventricular fibrillation.

7 an internal cardiac defibrillator shock for ventricular fibrillation.

8 n has focused on SCD-ventricular tachycardia/ventricular fibrillation.

9 am demonstrates continuous activities during ventricular fibrillation.

10 Late mortality was due to heart failure and ventricular fibrillation.

11 levels of CAR predispose to ischemia-induced ventricular fibrillation.

12 n was initiated after 6 minutes of untreated ventricular fibrillation.

13 surgery, 13.3% respiratory failure, and 8.4% ventricular fibrillation.

14 F hospitalization, HF death, and spontaneous ventricular fibrillation.

15 %) and 6 spontaneous ventricular tachycardia/ventricular fibrillation.

16 ence in dynamic properties between AF and VT/ventricular fibrillation.

17 termination of ventricular tachycardia (VT)/ventricular fibrillation.

18 ccessful appropriate ICD discharges were for ventricular fibrillation.

19 s of polymorphic ventricular tachycardia and ventricular fibrillation.

20 hmias due to Brugada syndrome and idiopathic ventricular fibrillation.

21 e submitted to coronary artery occlusion and ventricular fibrillation.

22 7.6% for all OHCA and 17.7% for OHCA due to ventricular fibrillation.

23 (ER) has recently been linked to idiopathic ventricular fibrillation.

24 h promotes the generation and maintenance of ventricular fibrillation.

25 receding ICD shocks distinguishes AF from VT/ventricular fibrillation.

26 ecular paradigm for some forms of idiopathic ventricular fibrillation.

27 urologic recovery after 15 mins of untreated ventricular fibrillation.

28 pacing at 200 and 300 beats per minute, and ventricular fibrillation.

29 under the most severe hemodynamic condition, ventricular fibrillation.

30 reduces induction of ventricular tachycardia/ventricular fibrillation.

31 after out-of-hospital cardiac arrest due to ventricular fibrillation.

32 tion was initiated after 7 mins of untreated ventricular fibrillation.

33 l effects were greatest in patients found in ventricular fibrillation.

34 d of SCD and 2 adults were resuscitated from ventricular fibrillation.

35 urologic function after 15 mins of untreated ventricular fibrillation.

36 rrest resulting from ventricular tachycardia/ventricular fibrillation.

37 hmic mortality and with an increased risk of ventricular fibrillation.

38 ding polymorphic ventricular tachycardia and ventricular fibrillation.

39 ersion of induced ventricular tachycardia or ventricular fibrillation.

40 icular and papillary muscle VE that triggers ventricular fibrillation.

41 aventricular tachycardias converted to VT or ventricular fibrillation.

42 There were 2 procedural deaths related to ventricular fibrillation.

43 s and in patients with no baseline inducible ventricular fibrillation.

44 cation tools for SCD-ventricular tachycardia/ventricular fibrillation.

45 first recurrence of ventricular tachycardia/ventricular fibrillation.

46 onnectivity that persists until the onset of ventricular fibrillation.

47 d to sudden cardiac arrest due to idiopathic ventricular fibrillation.

48 signals and a simulated patient experiencing ventricular fibrillation.

49 se (3 patients), or cardiac arrest caused by ventricular fibrillation (1 patient).

50 /day], intracranial haemorrhage [20 mg/day], ventricular fibrillation [120 mg/day], septic shock [80

51 ion of anesthesia and 7 minutes of untreated ventricular fibrillation, 16 female 3-month-old swine we

52 Protocol A: After 12 minutes of untreated ventricular fibrillation, 18 pigs were randomized to gro

53 thm was reported had ventricular tachycardia/ventricular fibrillation (189 of 283, 67%).

54 atrial fibrillation (14 cases) and postictal ventricular fibrillation (3 cases).

55 st (14%), ventricular tachycardia (58%), and ventricular fibrillation (6%).

56 cation revealed shocks were delivered for VT/ventricular fibrillation (62%), AF (23%), and supraventr

57 p < 0.001), had more ventricular tachycardia/ventricular fibrillation (81% vs 46%; p < 0.001), shorte

58 resuscitation (44% versus 25%; P=0.001) and ventricular fibrillation (84% versus 51%; P<0.0001).

59 often presented with ventricular tachycardia/ventricular fibrillation, a witnessed arrest, or had bys

60 ied out a study to compare response times to ventricular fibrillation across five patient loads: 16,

61 e, a 21q21 locus is strongly associated with ventricular fibrillation after myocardial infarction.

62 At 6 months, 1 patient in each group had ventricular fibrillation and 1 patient in each group die

63 4 and 17 seconds) for shocks that terminated ventricular fibrillation and 7 seconds (25th and 75th pe

64 ality is predicted by early recurrence of VT/ventricular fibrillation and ablation for electrical sto

65 iatric HCM proband with multiple episodes of ventricular fibrillation and aborted sudden cardiac deat

66 ssociated with lower prevalence of recurrent ventricular fibrillation and better postresuscitation my

67 ral highly dangerous heart diseases, such as ventricular fibrillation and congestive heart failure.

68 most episodes of ventricular tachycardia or ventricular fibrillation and decrease mortality in speci

69 Another fascinating area, idiopathic ventricular fibrillation and early repolarization syndro

70 of repetitive APs, leading in some cases to ventricular fibrillation and hemodynamic collapse in viv

71 nomic outflow significantly delayed terminal ventricular fibrillation and lengthened the duration of

72 pigs were subjected to 8.5 mins of untreated ventricular fibrillation and prospectively randomized to

73 ctrical activity in 874 children (84.8%) and ventricular fibrillation and pulseless ventricular tachy

74 ulseless electrical activity) and shockable (ventricular fibrillation and pulseless ventricular tachy

75 quisite for aging-dependent QT prolongation, ventricular fibrillation and SCD immediately after trans

76 t uncalibrated dynamic patterns of Im during ventricular fibrillation and show that Im at singularity

77 an trigger reentrant arrhythmias, leading to ventricular fibrillation and sudden cardiac death.

78 its effectiveness in detecting and treating ventricular fibrillation and tachycardia.

79 lood flow were measured in seven pigs before ventricular fibrillation and then following 6 minutes of

80 val of patients resuscitated from near-fatal ventricular fibrillation and those with sustained ventri

81 ined as aborted cardiac arrest or documented ventricular fibrillation and ventricular tachycardia (la

82 ac alternans has been linked to the onset of ventricular fibrillation and ventricular tachycardia, le

83 thetized pigs underwent 15 mins of untreated ventricular fibrillation and were subsequently randomize

84 th, ischemic stroke, ventricular tachycardia/ventricular fibrillation, and heart failure hospitalizat

85 ncluded acute respiratory distress syndrome, ventricular fibrillation, and hypotension.

86 senting rhythm of ventricular tachycardia or ventricular fibrillation, and lower S100B level.

87 ce of ventricular tachyarrhythmia, including ventricular fibrillation, and shock treatment was assess

88 Alternans has been linked to ventricular fibrillation, and thus the ability to predic

89 for VTA (including ventricular tachycardia, ventricular fibrillation, and ventricular flutter) was c

90 laglutide 0.75 mg group); cardiogenic shock; ventricular fibrillation; and an unknown cause (n=3 in t

91 ntable cardioverter defibrillator shocks for ventricular fibrillation; and n=8 without implantable ca

92 After 10 minutes of untreated ventricular fibrillation, animals were randomized to thr

93 g per se, but may increase susceptibility to ventricular fibrillation) are found to be associated wit

94 Non-ventricular fibrillation arrest and presence of cardioge

95 Patients with non-ventricular fibrillation arrest or cardiogenic shock wer

96 26.1%, and 3.6% had ventricular tachycardia/ventricular fibrillation arrest.

97 of presentation with ventricular tachycardia/ventricular fibrillation as opposed to pulseless electri

98 pressure, and therapeutic hypothermia after ventricular fibrillation-associated cardiac arrest.

99 Patients with no inducible ventricular fibrillation at baseline were left on no the

100 DE, and right ventricular DE for death or VT/ventricular fibrillation at mean follow-up of 48 months

101 After 3 minutes of cardiac arrest (ventricular fibrillation at t = 0 min), animals were ran

102 icular beats and prevented fatal episodes of ventricular fibrillation, but did not prevent QT prolong

103 termination of rapid ventricular tachycardia/ventricular fibrillation can reasonably be considered an

104 (eg, induced hypothermia for out-of-hospital ventricular fibrillation cardiac arrest and birth asphyx

105 Resuscitation from ventricular fibrillation cardiac arrest and rigorous tem

106 Animals underwent 30-minute untreated ventricular fibrillation cardiac arrest followed by extr

107 minutes of cardiopulmonary resuscitation for ventricular fibrillation cardiac arrest improves short-t

108 diopulmonary resuscitation is feasible after ventricular fibrillation cardiac arrest in rats and impr

109 In a rat model of 6-minute ventricular fibrillation cardiac arrest, cardiopulmonary

110 After 6 minutes of ventricular fibrillation cardiac arrest, resuscitation w

111 ompared with guideline care in this model of ventricular fibrillation cardiac arrest.

112 prove 24-hour survival in a porcine model of ventricular fibrillation cardiac arrest.

113 mary effectiveness end point was the induced ventricular fibrillation conversion rate compared with a

114 s 99%, and sensitivity analysis of the acute ventricular fibrillation conversion rate was >90% in the

115 f 88%, with success defined as 2 consecutive ventricular fibrillation conversions of 4 attempts.

116 ominant frequency (13.0 versus 10.0 Hz), and ventricular fibrillation duration (160 versus 80 s) were

117 tion restitution (APDR) curve and can reduce ventricular fibrillation duration in failing ventricles.

118 A recent genome-wide association study of ventricular fibrillation during acute myocardial infarct

119 A heritable component in the risk of ventricular fibrillation during myocardial infarction ha

120 Induction of ventricular tachycardia/ventricular fibrillation during programmed ventricular s

121 on and then following 6 minutes of untreated ventricular fibrillation during sequential 5 minutes tre

122 eath, sustained ventricular tachycardia, and ventricular fibrillation either documented on ECG or rec

123 Multichannel ventricular fibrillation electrogram data from 7 isolate

124 =1 ICD-treated ventricular tachycardias (VT)/ventricular fibrillation episode, or a recorded, sustain

125 A total of 34 ventricular tachyarrhythmia/ventricular fibrillation episodes (20 induced; 14 sponta

126 ents with repetitive ventricular tachycardia/ventricular fibrillation episodes alternating with perio

127 cluded a median of 7 ventricular tachycardia/ventricular fibrillation episodes.

128 290 eligible patients with no arrhythmia or ventricular fibrillation/flutter (CL<200 ms) induced in

129 received interventions for potentially fatal ventricular fibrillation/flutter episodes.

130 ducible ventricular tachycardia or inducible ventricular fibrillation/flutter) EPS result.

131 up of 16 pigs underwent 10 mins of untreated ventricular fibrillation followed by 3 mins of chest com

132 A protocol of 10 mins of untreated ventricular fibrillation followed by 5 mins of cardiopul

133 ge-free survival for ventricular tachycardia/ventricular fibrillation >/= 240 beats per minute was eq

134 ociated with an increased risk of idiopathic ventricular fibrillation (ID-VF).

135 lly intact survival of patients with OHCA in ventricular fibrillation improved in 2 rural counties in

136 test RR interval </=250 ms) in 0% to 9%, and ventricular fibrillation in 0% to 2%, most of whom were

137 tole in 61.5% and ventricular tachycardia or ventricular fibrillation in 24.1%.

138 ge of 65 +/- 12 years, a previous history of ventricular fibrillation in 37% of the cases, and a mean

139 tely to terminate ventricular tachycardia or ventricular fibrillation in 43 of 224 patients (19%) ove

140 During ventricular fibrillation in failing ventricles, the numb

141 ) were out-of-hospital SCA patients found in ventricular fibrillation in King County, WA.

142 Hypercholesterolemia protects against ventricular fibrillation in patients with myocardial inf

143 ts the recurrence of ventricular tachycardia/ventricular fibrillation in such patients.

144 s are critical in sustaining both atrial and ventricular fibrillation in the human heart and its impl

145 In contrast, in ventricular fibrillation in the setting of cardiac ische

146 ans, is believed to be a direct precursor of ventricular fibrillation in the whole heart.

147 hed reports of infants <3 months of age with ventricular fibrillation in which a primary diagnosis co

148 This is the first report of idiopathic ventricular fibrillation in young infants preceded by st

149 trict SCD hereafter to cardiac arrest due to ventricular fibrillation, including rhythms shockable by

150 During ischemia, ventricular tachycardia/ventricular fibrillation inducibility was larger in WT t

151 disappearance and no ventricular tachycardia/ventricular fibrillation inducibility without complicati

152 rdial substrate, and ventricular tachycardia/ventricular fibrillation inducibility.

153 BrS ECG pattern, and ventricular tachycardia/ventricular fibrillation inducibility.

154 A subset of MRI patients underwent ventricular fibrillation induction testing post-MRI to c

155 inidine for atrial fibrillation who develops ventricular fibrillation is diagnosed with "acquired LQT

156 Understanding the mechanisms that drive ventricular fibrillation is essential for developing imp

157 tion testing by induction and termination of ventricular fibrillation is widely done at the time of i

158 After 15 mins of untreated ventricular fibrillation, isoflurane-anesthetized pigs r

159 Idiopathic ventricular fibrillation (IVF) is a rare cause of sudden

160 e genetic defect in a family with idiopathic ventricular fibrillation (IVF) manifesting in childhood

161 tions included pulmonary hemorrhage (n = 2), ventricular fibrillation (n = 1), and stent migration (n

162 on and included atrial fibrillation (n = 4), ventricular fibrillation (n = 6), supraventricular tachy

163 and Lange-Nielsen syndrome (n=5), idiopathic ventricular fibrillation (n=4), left ventricular noncomp

164 s, such as SCD (n=1), aborted SCD because of ventricular fibrillation (n=6), sustained ventricular ta

165 n = 36; polymorphic ventricular tachycardia/ventricular fibrillation, n = 14; other, n = 11), includ

166 ich a cluster of ventricular tachycardias or ventricular fibrillation, negatively affects short- and

167 Detection was set to ventricular fibrillation number of intervals to detect=2

168 the majority of SCD-ventricular tachycardia/ventricular fibrillation occurs in patients without know

169 In contrast, rates of ventricular fibrillation or cardiac arrest were higher o

170 ak troponin, prior MI, and presentation with ventricular fibrillation or cardiac arrest.

171 DE was associated with risk of VT/ventricular fibrillation or death (P=0.0032 for any DE a

172 associated with ventricular tachycardia (VT)/ventricular fibrillation or death in patients with cardi

173 pulseless electrical activity, and 20.7% had ventricular fibrillation or pulseless ventricular tachyc

174 We assessed the frequencies of ventricular fibrillation or pulseless ventricular tachyc

175 The adjusted odds ratio for initial ventricular fibrillation or pulseless ventricular tachyc

176 or cardiac arrests at home, the incidence of ventricular fibrillation or pulseless ventricular tachyc

177 of-hospital cardiac arrest, shock-refractory ventricular fibrillation or pulseless ventricular tachyc

178 g and whose initial cardiac-arrest rhythm of ventricular fibrillation or pulseless ventricular tachyc

179 hospital cardiac arrest for shock-refractory ventricular fibrillation or pulseless ventricular tachyc

180 rdiac arrest due to initial shock-refractory ventricular fibrillation or pulseless ventricular tachyc

181 sudden cardiac death or nonfatal episode of ventricular fibrillation or sustained ventricular tachyc

182 ifekalant (NIF) are used in the treatment of ventricular fibrillation or tachycardia; however, only f

183 ned as arrhythmic death or ICD discharge for ventricular fibrillation or ventricular tachycardia >240

184 lantable cardiac defibrillator discharge for ventricular fibrillation or ventricular tachycardia >240

185 The risk of ventricular tachycardia, ventricular fibrillation, or death was decreased signifi

186 No inducible arrhythmia, ventricular fibrillation, or flutter (cycle length <200

187 th, ischemic stroke, ventricular tachycardia/ventricular fibrillation, or heart failure hospitalizati

188 There were no cases of torsades de pointes, ventricular fibrillation, or polymorphic or sustained ve

189 ths who died due to ventricular tachycardia, ventricular fibrillation, or sudden unexpected death, or

190 aborted SCD (appropriate ICD shock, nonfatal ventricular fibrillation, or sustained ventricular tachy

191 d a better survival than those in refractory ventricular fibrillation (p = 0.017).

192 h was associated with early recurrence of VT/ventricular fibrillation (P=0.003) and ablation for elec

193 F hospitalization, HF death, and spontaneous ventricular fibrillation (P=0.028).

194 Clinical data in 5 idiopathic ventricular fibrillation patients suggested arrhythmia o

195 During ventricular fibrillation, peak I(m) was decreased by 50%

196 After 7 minutes of ventricular fibrillation, pigs were randomized to receiv

197 ardia (hazard ratio [HR]: 1.65, p < 0.0001), ventricular fibrillation/polymorphic ventricular tachyca

198 rm survival in patients with shock-resistant ventricular fibrillation /pulseless ventricular tachycar

199 om out-of-hospital cardiac arrest because of ventricular fibrillation, pulseless ventricular tachycar

200 rm and long-term survival in shock-resistant ventricular fibrillation/pulseless ventricular tachycard

201 ockable rhythms evolve to shockable rhythms (ventricular fibrillation/pulseless ventricular tachycard

202 ntaneous episodes of ventricular tachycardia/ventricular fibrillation recorded in 21 patients (6.7%),

203 int of time to first ventricular tachycardia/ventricular fibrillation recurrence.

204 Only bileaflet MVP was associated with ventricular fibrillation recurrences requiring ICD thera

205 Resistant ventricular fibrillation, refibrillation.

206 icial circulation and defibrillation to halt ventricular fibrillation remain of paramount importance

207 5, PKP2-p.Arg79X, and the Chr7q36 idiopathic ventricular fibrillation risk haplotype) in a cohort of

208 After prolonged untreated ventricular fibrillation, sodium nitroprusside-enhanced

209 ccess was seen in 17 of 19 procedures, and a ventricular fibrillation storm occurred within 24 hours

210 eant for identifying atrial fibrillation and ventricular fibrillation substrate may allow us to recor

211 nsplantation, survived sudden cardiac death, ventricular fibrillation, sustained ventricular tachycar

212 OHCA survival from shockable arrhythmias (ventricular fibrillation/ tachycardia) improved in sever

213 13 of 24 patients (54%) received appropriate ventricular fibrillation-terminating ICD shocks.

214 BCE was defined as either (1) an appropriate ventricular fibrillation-terminating implantable cardiov

215 eizures, aborted cardiac arrest, appropriate ventricular fibrillation-terminating implantable cardiov

216 tion between pauses for all reasons and both ventricular fibrillation termination and patient surviva

217 d by chest compression fraction or decreased ventricular fibrillation termination rate.

218 Ventricular fibrillation termination was not the mechani

219 an IHCA caused by ventricular tachycardia or ventricular fibrillation, the rate of 1-year survival wa

220 acing of 200 and 300 beats per minute, under ventricular fibrillation, the right atrium-aorta system

221 When the simulated patient sustained ventricular fibrillation, the time required to report th

222 e more prevalent in patients with idiopathic ventricular fibrillation, their ability to predict cardi

223 cetylcholine analogue carbamylcholine raises ventricular fibrillation threshold (VFT) and flattens th

224 stable analogue of acetylcholine could raise ventricular fibrillation threshold (VFT), and whether th

225 Purkinje origin VE was identified as the ventricular fibrillation trigger in 6 of 6 cardiac arres

226 nt was occurrence of ventricular tachycardia/ventricular fibrillation-triggered ICD interventions (sh

227 hs, 230-740 ms, arrhythmic storm n=28) and 2 ventricular fibrillation triggers were targeted (25 tran

228 All but 6 of the 66 patients with inducible ventricular fibrillation underwent electrophysiological

229 ulmonary resuscitation 37%; initial rhythms: Ventricular fibrillation/ventricular tachycardia 24%, pu

230 t failure symptoms, shockable arrest rhythm (ventricular fibrillation/ventricular tachycardia), and S

231 fibrillation (AF) (n = 13), or scar-related ventricular fibrillation (VF) (n = 3) were examined.

232 ving documented ventricular tachycardia (VT)/ventricular fibrillation (VF) and Brugada syndrome-relat

233 erized a family presenting with a history of ventricular fibrillation (VF) and sudden death without e

234 Over the last decades, a gradual decrease in ventricular fibrillation (VF) as initial recorded rhythm

235 ized that dantrolene improves survival after ventricular fibrillation (VF) by rectifying the calcium

236 the hypothesis that PH promotes spontaneous ventricular fibrillation (VF) during a critical post-PH

237 Spontaneous ventricular tachyarrhythmia (VT)/ventricular fibrillation (VF) events (n=111) were treate

238 endocardial activation during long-duration ventricular fibrillation (VF) exhibits organized activit

239 Ventricular fibrillation (VF) has been proposed to be ma

240 n (APD) shortening and recurrent spontaneous ventricular fibrillation (VF) in failing ventricles.

241 incidence of ventricular tachycardia (VT) or ventricular fibrillation (VF) in patients with heart fai

242 tested the hypothesis that ischemia-induced ventricular fibrillation (VF) is facilitated by platelet

243 defined as a rate faster than 180 beats/min)/ventricular fibrillation (VF) or death (primary endpoint

244 e the percentage of patients who experienced ventricular fibrillation (VF) or potentially malignant a

245 l cardiac arrest has raised the concern that ventricular fibrillation (VF) recurrence may be triggere

246 Reperfusion-induced ventricular fibrillation (VF) severely threatens the liv

247 This study mapped human ventricular fibrillation (VF) to define mechanistic diff

248 ess the feasibility of terminating sustained ventricular fibrillation (VF) via light-induced excitati

249 Susceptibility to ventricular fibrillation (VF) was evaluated using a 2-mi

250 Ventricular fibrillation (VF) waveform properties have b

251 D) or sustained ventricular tachycardia (VT)/ventricular fibrillation (VF) with appropriate ICD thera

252 After defibrillation of initial ventricular fibrillation (VF), it is crucial to prevent

253 aimed to study whether AF is associated with ventricular fibrillation (VF), the most common cause of

254 eart can lead to cardiac arrhythmias such as ventricular fibrillation (VF), which in turn compromise

255 permits therapy for ventricular tachycardia/ventricular fibrillation (VF).

256 a canine model of post-myocardial infarction ventricular fibrillation (VF).

257 fficacy is tested at implant by induction of ventricular fibrillation (VF).

258 olazine suppresses re-entrant and multifocal ventricular fibrillation (VF).

259 roved defibrillation techniques to terminate ventricular fibrillation (VF).

260 e ventricular excitation (PVEM) and, rarely, ventricular fibrillation (VF).

261 ced ICD-treated ventricular tachycardia (VT)/ventricular fibrillation (VF).

262 first clinic visit were analyzed to predict ventricular fibrillation (VF)/SCD during follow-up.

263 atients with refractory out-of-hospital (OH) ventricular fibrillation (VF)/ventricular tachycardia (V

264 A are associated with conduction disease and ventricular fibrillation (VF); however, the mechanisms t

265 omyopathy (HCM), and ventricular tachycardia-ventricular fibrillation (VT-VF).

266 ognosis of sustained ventricular tachycardia/ventricular fibrillation (VT/VF) in contemporary non-ST-

267 fraction, including ventricular tachycardia/ventricular fibrillation (VT/VF).

268 thms of ventricular tachycardia or pulseless ventricular fibrillation (VT/VF).

269 tricular arrhythmia (ventricular tachycardia/ventricular fibrillation [VT/VF]), stage C heart failure

270 ccuracy of sustained ventricular tachycardia/ventricular fibrillation (VTs/VF) inducibility and to id

271 th initial rhythm of ventricular tachycardia/ventricular fibrillation was 56%, of whom 82 had a compl

272 Inducibility of ventricular tachycardia/ventricular fibrillation was associated with an increase

273 or IHCA caused by ventricular tachycardia or ventricular fibrillation was associated with higher rate

274 Ventricular fibrillation was electrically induced in 30

275 stimulation-induced ventricular tachycardia/ventricular fibrillation was equivalent in all groups (P

276 illation in patients who were found to be in ventricular fibrillation was included in the propensity

277 7 mins following endotracheal tube clamping, ventricular fibrillation was induced and remained untrea

278 Ventricular fibrillation was induced and untreated for 6

279 Ventricular fibrillation was induced and untreated for 8

280 Ventricular fibrillation was induced in 30 male domestic

281 Ventricular fibrillation was induced in 66 patients, inc

282 Ventricular fibrillation was induced in 9 of 12 CKD rats

283 Ventricular fibrillation was induced, and defibrillation

284 ts (group II), where ventricular tachycardia/ventricular fibrillation was not induced.

285 arge diagnosis of ventricular tachycardia or ventricular fibrillation was performed.

286 rate terminating ventricular tachycardia or ventricular fibrillation was the same in patients who un

287 Ventricular tachycardia/ventricular fibrillation was triggered in 44 patients (g

288 ricular tachycardia (VT) >/=240 beats/min or ventricular fibrillation, was a younger age at enrollmen

289 zed by renin and norepinephrine overflow and ventricular fibrillation, was potentiated ( approximatel

290 r ICD discharges for ventricular tachycardia/ventricular fibrillation were equivalent to an aborted d

291 Two patterns of onset of ventricular fibrillation were observed and were reproduc

292 used by pulseless ventricular tachycardia or ventricular fibrillation were stratified by prompt (</=2

293 Episodes of ventricular fibrillation were uniformly successfully tre

294 efibrillation for ventricular tachycardia or ventricular fibrillation) were analyzed with multivariat

295 illation: A Validation on 1617 Patients With Ventricular Fibrillation," which was published in the Fe

296 ss electrical activity/asystole or resistant ventricular fibrillation who were treated with mild ther

297 ttempted to defibrillate after 10 seconds of ventricular fibrillation with a single approximately 30-

298 After prolonged ventricular tachycardia/ventricular fibrillation without resuscitation, asystole

299 tachycardia zone) and at rates >/= 200 bpm (ventricular fibrillation zone).

300 adjusted) in the VT zone, and 6 of 10 in the ventricular fibrillation zone.